Structure-based drug design of 1,3,6-trisubstituted 1,4-diazepan-7-ones as selective human kallikrein 7 inhibitors

被引：8
|
作者：
Murafuji, Hidenobu [1 ]
Sakai, Hiroki [1 ,2 ]
Goto, Megumi [1 ,2 ]
Oyama, Yoshiaki [1 ]
Imajo, Seiichi [1 ]
Sugawara, Hajime [1 ]
Tomoo, Toshiyuki [1 ]
Muto, Tsuyoshi [1 ]
机构：
[1] Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[2] Daiichi Sankyo Co Ltd, Shinagawa R&D Ctr, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2018年 / 28卷 / 08期
关键词：
Atopic dermatitis; Serine protease; Kallikrein; 7; inhibitor; 1,4-Diazepan-7-one; Structure-based drug design; EPIDERMAL BARRIER DYSFUNCTION; ATOPIC-DERMATITIS; STRATUM-CORNEUM; SERINE PROTEASES; DESQUAMATION; EXPRESSION; SKIN;
D O I：
10.1016/j.bmcl.2018.03.011
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A novel series of 1,3,6-trisubstituted 1,4-diazepan-7-ones were investigated as human kallikrein 7 (KLK7, stratum corneum chymotryptic enzyme) inhibitors. Based on the X-ray co-crystal structure of compound 1 bound to human KLK7, the derivatives of this scaffold were designed, synthesized, and evaluated. Through structure-activity relationship studies focused on the side chain located in the prime site region of the enzyme, representative compounds 15, 33a, and 35a were identified as highly potent and selective inhibitors of human KLK7. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1371 / 1375
页数：5
相关论文
共 50 条
  • [1] Structure-based drug design to overcome species differences in kallikrein 7 inhibition of 1,3,6-trisubstituted 1,4-diazepan-7-ones
    Murafuji, Hidenobu
    Sugawara, Hajime
    Goto, Megumi
    Oyama, Yoshiaki
    Sakai, Hiroki
    Imajo, Seiichi
    Tomoo, Toshiyuki
    Muto, Tsuyoshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3639 - 3653
  • [2] 3D-QSAR, HQSAR, molecular docking, and new compound design study of 1,3,6-trisubstituted 1,4-diazepan-7-ones as human KLK7 inhibitors
    Fu, Le
    Chen, Yi
    Xu, Chun-mei
    Wu, Tao
    Guo, Hong-mei
    Lin, Zhi-hua
    Wang, Rui
    Shu, Mao
    MEDICINAL CHEMISTRY RESEARCH, 2020, 29 (06) : 1012 - 1029
  • [3] 3D-QSAR, HQSAR, molecular docking, and new compound design study of 1,3,6-trisubstituted 1,4-diazepan-7-ones as human KLK7 inhibitors
    Le Fu
    Yi Chen
    Chun-mei Xu
    Tao Wu
    Hong-mei Guo
    Zhi-hua Lin
    Rui Wang
    Mao Shu
    Medicinal Chemistry Research, 2020, 29 : 1012 - 1029
  • [4] Discovery and structure-activity relationship study of 1,3,6-trisubstituted 1,4-diazepane-7-ones as novel human kallikrein 7 inhibitors
    Murafuji, Hidenobu
    Sakai, Hiroki
    Goto, Megumi
    Imajo, Seiichi
    Sugawara, Hajime
    Muto, Tsuyoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5272 - 5276
  • [5] Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
    Wang, Zhen
    Bian, Huan
    Bartual, Sergio G.
    Du, Wenting
    Luo, Jinfeng
    Zhao, Hu
    Zhang, Shasha
    Mo, Cheng
    Zhou, Yang
    Xu, Yong
    Tu, Zhengchao
    Ren, Xiaomei
    Lu, Xiaoyun
    Brekken, Rolf A.
    Yao, Libo
    Bullock, Alex N.
    Su, Jin
    Ding, Ke
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (12) : 5911 - 5916
  • [6] Drug promiscuity: Exploring the polypharmacology potential of 1, 3, 6-trisubstituted 1, 4-diazepane-7-ones as an inhibitor of the 'god father' of immune checkpoint
    Soremekun, Opeyemi S.
    Olotu, Fisayo A.
    Agoni, Clement
    Soliman, Mahmoud E. S.
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 80 : 433 - 440
  • [7] Structure-Based Design of Potent and Selective CK1γ Inhibitors
    Huang, Hongbing
    Acquaviva, Lisa
    Berry, Virginia
    Bregman, Howard
    Chakka, Nagasree
    O'Connor, Anne
    DiMauro, Erin F.
    Dovey, Jennifer
    Epstein, Oleg
    Grubinska, Barbara
    Goldstein, Jon
    Gunaydin, Hakan
    Hua, Zihao
    Huang, Xin
    Huang, Liyue
    Human, Jason
    Long, Alex
    Newcomb, John
    Patel, Vinod F.
    Saffran, Doug
    Serafino, Randy
    Schneider, Steve
    Strathdee, Craig
    Tang, Jin
    Turci, Susan
    White, Ryan
    Yu, Violeta
    Zhao, Huilin
    Wilson, Cindy
    Martin, Matthew W.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (12): : 1059 - 1064
  • [8] Structure-Based Drug Design, Synthesis and Antitumor Activities of Novel CDK7 Inhibitors
    Liu Tao
    Sun Mao-Tang
    Dong Xiao-Wu
    Ren Xin
    Yang Xin
    Du Li-Lin
    Hu Yong-Zhou
    ACTA PHYSICO-CHIMICA SINICA, 2009, 25 (10) : 2107 - 2112
  • [9] Structure-Based Drug Design of Novel Potent and Selective Tetrahydropyrazolo[1,5-a]pyrazines as ATR Inhibitors
    Barsanti, Paul A.
    Aversa, Robert J.
    Jin, Xianming
    Pan, Yue
    Lu, Yipin
    Elling, Robert
    Jain, Rama
    Knapp, Mark
    Lan, Jiong
    Lin, Xiaodong
    Rudewicz, Patrick
    Sim, Janet
    Taricani, Lorena
    Thomas, George
    Xiao, Linda
    Yue, Qin
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (01): : 37 - 41
  • [10] Structure-Based Design of Selective LONP1 Inhibitors for Probing In Vitro Biology
    Kingsley, Laura J.
    He, Xiaohui
    McNeill, Matthew
    Nelson, John
    Nikulin, Victor
    Ma, Zhiwei
    Lu, Wenshuo
    Zhou, Vicki W.
    Manuia, Mari
    Kreusch, Andreas
    Gao, Mu-Yun
    Witmer, Darbi
    Vaillancourt, Mei-Ting
    Lu, Min
    Greenblatt, Sarah
    Lee, Christian
    Vashisht, Ajay
    Bender, Steven
    Spraggon, Glen
    Michellys, Pierre-Yves
    Jia, Yong
    Haling, Jacob R.
    Lelais, Gerald
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (08) : 4857 - 4869
12345